4D Molecular Therapeutics, Inc. (FDMT)

$15.07 -2.84% $-0.44 Healthcare

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.

$783.18M

Dr. David H. Kirn M.D.

140.00

EmeryVille, CA

Dec 11, 2020

-6.79

$-2.22

16.80

32.65

-511.23%

-8.45

-0.23

1.47

45.35

32.06

-16.60%

-48.32%

Similar stocks (15)

Revolution Medicines, Inc.

RVMD

$41.84 -3.24%
Neutral

Akero Therapeutics, Inc.

AKRO

$26.41 0.23%
Uptrend

Edgewise Therapeutics, Inc.

EWTX

$17.52 0.29%
Neutral

Cullinan Oncology, Inc.

CGEM

$17.98 0.28%
Uptrend

Stoke Therapeutics, Inc.

STOK

$14.70 -2.97%
Uptrend

Replimune Group, Inc.

REPL

$10.37 -3.26%
Uptrend

C4 Therapeutics, Inc.

CCCC

$5.40 -7.38%
Downtrend

Black Diamond Therapeutics, Inc.

BDTX

$5.40 -3.23%
Neutral

Biomea Fusion, Inc.

BMEA

$7.08 -6.96%
Downtrend

Gossamer Bio, Inc.

GOSS

$0.91 -5.28%
Downtrend

Century Therapeutics, Inc.

IPSC

$1.46 1.39%
Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.18 0.32%
Downtrend

Kronos Bio, Inc.

KRON

$0.98 -0.10%
Downtrend

Passage Bio, Inc.

PASG

$0.70 9.98%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 -4.35%
Downtrend

ETF Exposure (43)

Franklin Genomic Advancements ETF

HELX

0.81%

$32.14 -0.54%
Neutral

iShares Genomics Immunology and Healthcare ETF

IDNA

0.75692%

$23.93 -1.56%
Neutral

iShares Micro-Cap ETF

IWC

0.20709%

$117.00 -1.56%
Neutral

SPDR S&P Biotech ETF

XBI

0.207076%

$96.52 -1.59%
Neutral

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.1451915958%

$121.08 -4.95%
Neutral

BlackRock Future Health ETF

BMED

0.08795%

$25.62 -0.98%
Neutral

Invesco Nasdaq Biotechnology ETF

IBBQ

0.08%

$23.54 -1.09%
Neutral

SPDR S&P Kensho New Economies Composite ETF

KOMP

0.067988%

$45.43 -2.24%
Downtrend

iShares Biotechnology ETF

IBB

0.06435%

$142.75 -1.41%
Neutral

Vanguard U.S. Momentum Factor ETF

VFMO

0.05%

$148.12 -2.24%
Neutral

Vanguard Russell 2000 Growth Index Fund

VTWG

0.04%

$192.10 -2.05%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.0391%

$263.74 -2.06%
Neutral

iShares Russell 2000 ETF

IWM

0.03014%

$207.90 -1.90%
Neutral

Vanguard Russell 2000 Index Fund

VTWO

0.03%

$84.07 -1.90%
Neutral

Schwab U.S. Small-Cap ETF

SCHA

0.0234991041%

$48.38 -1.79%
Neutral

ProShares Ultra Nasdaq Biotechnology

BIB

0.023129742513393257%

$62.27 -2.67%
Neutral

iShares Russell 2000 Value ETF

IWN

0.02129%

$159.29 -1.60%
Neutral

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$140.31 -1.72%
Neutral

ProShares Ultra Russell2000

UWM

0.011446850738937885%

$38.11 -3.79%
Neutral

Vanguard Health Care Index Fund

VHT

0.01%

$281.39 -0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.01%

$129.08 -1.69%
Neutral

Vanguard Extended Market Index Fund

VXF

0.01%

$170.15 -1.70%
Neutral

Fidelity MSCI Health Care Index ETF

FHLC

0.0069409%

$72.50 -0.60%
Uptrend

ProShares UltraPro Russell2000

URTY

0.005642323743225085%

$43.69 -5.88%
Downtrend

ALPS Medical Breakthroughs ETF

SBIO

0.0056%

$36.06 -0.95%
Uptrend

ProShares Hedge Replication ETF

HDG

0.004788983979705789%

$49.22 -0.58%
Neutral

Dimensional U.S. Core Equity 2 ETF

DFAC

0.00455609%

$32.31 -1.55%
Neutral

Dimensional U.S. Small Cap ETF

DFAS

0.00410344%

$60.95 -1.80%
Neutral

SPDR Portfolio MSCI Global Stock Market ETF

SPGM

0.002704%

$60.71 -1.75%
Neutral

Schwab U.S. Broad Market ETF

SCHB

0.0014833197%

$62.54 -1.70%
Neutral

Dimensional US Core Equity Market ETF

DFAU

0.00145804%

$37.31 -1.58%
Neutral

iShares Russell 3000 ETF

IWV

0.00136%

$307.60 -1.67%
Neutral

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00131%

$118.26 -1.64%
Neutral

Dimensional U.S. Equity ETF

DFUS

5.436e-4%

$58.37 -1.85%
Neutral

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$48.18 -0.99%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$48.17 -0.99%
Neutral

Vanguard Balanced Index Fund

VBINX

0%

$48.17 -0.99%
Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$92.34 -1.71%
Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$92.32 -1.71%
Neutral

Vanguard Total Stock Market Index Fund

VITSX

0%

$129.67 -1.71%
Neutral

Vanguard Russell 3000 Index Fund

VTHR

0%

$238.81 -1.74%
Neutral

Vanguard Total Stock Market Index Fund

VTI

0%

$266.44 -1.66%
Neutral

Vanguard Total Stock Market Index Fund

VTSAX

0%

$129.65 -1.71%
Neutral